A hematologist specializing in hematopoietic stem cell transplantation, Dr. Jean Roy has been the Maryse and William Brock Chair in Applied Research into Stem Cell Transplantation at Université de Montréal since 2016. A clinical researcher who is very involved in his field, Dr. Roy has published over 60 papers and presented 200 abstracts at provincial, national and international conferences. He regularly serves as a scientific advisor and reviewer and teaches as a full professor in the Department of Medicine in the Faculty of Medicine at Université de Montréal.
Dr. Jean Roy is a member of the Hematopoietic Stem Cell Transplant Clinical Research Unit. He is particularly interested in multiple myeloma and allogeneic transplantation to cure this disease. His projects aim to make allogeneic transplantation more effective and less toxic for patients, for example, through the use of myeloma drugs post-transplantation or the use of cord cells expanded with UM171 to achieve a more potent antimyeloma effect.
PublicationsVoir toutes les publications
Ahmad I, LeBlanc R, Cohen S, Lachance S, Kiss T, Sauvageau G, Roy DC, Busque L, Delisle JS, Bambace N, Bernard L and Roy J. Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. Bone Marrow Transplantation 2016;51;529-535.
Sandra Cohen, Jean Roy, Silvy Lachance, Jean-Sébastien Delisle, Anne Marinier, Lambert Busque, Denis Claude Roy, Frédéric Barabé, Imran Ahmad, Nadia Bambace, Léa Bernard, Thomas Kiss, Philippe Bouchard, Pierre Caudrelier, Séverine Landais, Fannie Larochelle, Jalila Chagraoui, Bernhard Lehnertz, Sophie Corneau, Elisa Tomellini, Jeroen J.A. van Kampen, Jan J. Cornelissen, Maude Dumont-Lagacé, Mégane Tanguay, Qi Li, Sébastien Lemieux, Peter W. Zandstra, Guy Sauvageau. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study. Lancet Haematology 2020;7:134-145.
Richard LeBlanc, Jean-Sébastien Claveau, Imran Ahmad, Séverine Landais, Nadia Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Thomas Kiss, Silvy Lachance, Guy Sauvageau, Denis Claude Roy and Jean Roy. Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. Clinical Transplantation 2020. doi: 10.1111/ctr.14099.
Fellow in internal medicine and hematology
Royal College of Physicians and Surgeons of Canada (FRCPC)
Fellowship in hematopoietic stem cell transplantation and clinical research
University of Minnesota, Minneapolis, Minnesota
Residency in hematology
Residency in internal medicine
Université Laval and McGill University
Doctor of Medicine
Université Laval, Québec
- 2017 Award for scientific excellence (Collège des médecins du Québec)